Physician profile

Erica E Marsh

Obstetrics & Gynecology · Ann Arbor, MI

NPI 1487818134

$36,343.78

in general payments reported to CMS, 2019-2025

5 companies · $17K in 2025

The $17K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$21,475.00
Travel and Lodging$4,891.46
Food and Beverage$217.63

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Ferring Pharmaceuticals INC. $20,240.33 2022-2025
Myovant Sciences INC. $9,262.86 2021-2022
Alnylam Pharmaceuticals INC. $6,440.00 2023
Pfizer INC. $400.59 2021-2022

1 company reported research payments only; those appear in the research section below.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Erica E Marsh

$36,343.78

in general payments reported 2019-2025

Years
2021-2025
Top company
Ferring Pharmaceuticals INC.
Context
The $17K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

https://glasscript.com/doctor/203853/erica-e-marsh

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.